Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piclidenoson in moderate-to-severe plaque psoriasis
NCT06643260Phase 3Not yet recruiting
- Sponsor
- Can-Fite BioPharma Ltd.
- Start
- Jun 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of piclidenoson in plaque psoriasis, sponsored by Can-Fite BioPharma Ltd.. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
piclidenoson
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06643260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06643260.